Latest concept of Lewy body disease

Psychiatry and Clinical Neurosciences

Volumn 68, Issue 6, 2014, Pages 391-394

  Kosaka, Kenji ^a  

^a Medical Care Court Clinic ^*  (Japan)

Author keywords

dementia with Lewy bodies; diffuse Lewy body disease; Lewy body disease; Parkinson's disease; Parkinson's disease with dementia

Indexed keywords

ALPHA SYNUCLEIN;

ADRENERGIC SYSTEM; BRAIN STEM; DEMENTIA; DIFFUSE LEWY BODY DISEASE; HUMAN; LEWY BODY; NEUROPATHOLOGY; PARKINSON DISEASE; REVIEW; BRAIN; NOMENCLATURE; PATHOLOGY;

BRAIN; HUMANS; LEWY BODY DISEASE; PARKINSON DISEASE; TERMINOLOGY AS TOPIC;

EID: 84901915163     PISSN: 13231316     EISSN: 14401819     Source Type: Journal    
DOI: 10.1111/pcn.12179     Document Type: Review

References (40)

1. Kosaka K, Matsushita M, Ooyanagi S, Mehraein P,. Clinicopathological study of Lewy body disease. Psychiat. Neurol. Jap. 1980; 82: 292-311 (in Japanese).
2. McKeith IG, Dickson DW, Lowe J, et al. Diagnosis and management of dementia with Lewy bodies: Third report of the DLB Consortium. Neurology 2005; 65: 1863-1872.
3. Lippa CF, Duda JE, Grossman M, et al. DLB and PDD boundary issues. Diagnosis, treatment, molecular pathology, and biomarkers. Neurology 2007; 68: 812-819.
4. Lewy FH,. Paralysis Agitans. I. Pathologische Anatomie. In:, Lewandowsky M, (ed.). Handbuch Der Neurologie, Vol 3. Springer, Berlin, 1912; 920-958.
5. Tretiakoff C,. Contribution a l'etude de l'Anatomie pathologique du Locus Niger de Soemmering avec quelques deductionrelatives a la pathogenie des troubles du tonus musculaire et de la maladie de Parkinson. Theses de Paris. 1919.
6. Greenfeeld JG, Bosanque FD,. The brain-stem lesions in Parkinsonism. J. Neurol. Neurosurg. Psychiatry 1953; 10: 213-216.
7. Bethlem J, Den Haltog Jager WA,. The incidence and characteristics of Lewy bodies in idiopathic paralysis agitans (Parkinson's disease). J Neurol Psychiatry 1960; 23: 74-80.
8. Okazaki H, Lipkin LE, Aronson SM,. Diffuse intracytoplasmic ganglionic inclusions (Lewy type) associated with progressive dementia and quadriparesis in flexion. J. Neuropathol. Exp. Neurol. 1961; 20: 237-244.
9. Kosaka K, Oyanagi S, Matsushita M, Hori A,. Presenile dementia with Alzheimer-, Pick- and Lewy body changes. Acta Neuropathol. 1976; 36: 221-233.
10. Kosaka K,. Lewy bodies in cerebral cortex; report of three cases. Acta Neuropathol. 1978; 42: 127-134.
11. Kosaka K, Mehraein P,. Dementia-Parkinsonism syndrome with numerous Lewy bodies and senile plaques in cerebral cortex. Arch. Psychiatr. Nervenkr. 1979; 226: 241-250.
12. Kosaka K, Yoshimura M, Ikeda K, Budka H,. Diffuse type of Lewy body disease. A progressive dementia with numerous cortical Lewy bodies and senile changes of various degree. A new disease? Clin. Neuropathol. 1984; 3: 185-192.
13. Kosaka K, Iseki E, Odawara T, Yamamoto T,. Cerebral type of Lewy body disease. Neuropathology 1996; 1: 32-35.
14. Yoshimura M,. Cortical changes in the Parkinsonian brain: A contribution to the delineation of 'diffuse Lewy body disease'. J. Neurol. 1983; 229: 17-32.
15. Kosaka K,. Diffuse Lewy body disease in Japan. J. Neurol. 1990; 237: 197-204.
16. Kosaka K,. Diffuse Lewy-Koerperchen Krankheit: Vergleich klinisch-pathologischer Daten zwischen Japanischen und Europaeischen/ Amerikanischen Faellen. 150. Jahren Psychiatrie in Deutschlnd. 1992.
17. Perry RH, Irving D, Blessed G, Fairbairn A, Perry EK,. Senile dementia of Lewy body type. A clinically and neuropathologically distinct form of Lewy body dementia in the elderly. J. Neurol. Sci. 1990; 95: 119-139.
18. Hansen L, Salmon D, Galasko D, et al. The Lewy body variant of Alzheimer's disease. A clinical and pathological entity. Neurology 1990; 40: 1-8.
19. Kosaka K, Iseki E,. Diffuse Lewy body disease within the spectrum of Lewy body disease. In:, Perry R, McKeith I, Perry E, (eds). Dementia with Lewy Bodies. Clinical, Pathological and Treatment Issues. Cambridge University Press, Cambridge, 1996; 238-247.
20. Perry R, McKeith I, Perry E,. Dementia with Lewy Bodies. Clinical, Pathological, and Treatment Issues. Cambridge University Press, Cambridge, 1996.
21. McKeith IG, Galasko D, Kosaka K, et al. Consensus guidelines for the clinical and pathological diagnosis of dementia with Lewy bodies (DLB). Neurology 1996; 47: 1113-1124.
22. McKeith IG, Perry EK, Perry RH,. Report of the second dementia with Lewy body international workshop. Neurology 1999; 53: 902-906.
23. Japan DLB Research Association. The Front Line of Japan DLB Research, the Fifth Anniversary 2012.
24. Aarsland D, Rongve A, Nore SP, et al. Frequency and case identification of dementia with Lewy bodies using the revised consensus criteria. Dement. Geriatr. Cogn. Disord. 2008; 26: 445-452.
25. Walker Z, Jaros E, Walker RMW, et al. Dementia with Lewy bodies: A comparison of clinical diagnosis, FP-CIT single photon emission computed tomography imaging and autopsy. J. Neurol. Neurosurg. Psychiatry 2007; 78: 1176-1181.
26. Yoshita M, Taki J, Yamada M,. A clinical role for [231}MIBG myocardial scintigraphy in the distinction between dementia of the Alzheimer's type and dementia with Lewy bodies. J. Neurol. Neurosurg. Psychiatry 2001; 71: 583-588.
27. Polymeropoulos MH, Lavedan C, Leroy E, et al. Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 1997; 276: 2045-2047.
28. Singleton AB, Farrer M, Johnson J, et al. α-synuclein locus triplication causes Parkinson's disease. Science 2003; 302: 841.
29. Farrer M, Kachergus J, Forno L, et al. Comparison of kindreds with parkinsonism and α-synuclein genomic multiplication. Ann. Neurol. 2004; 55: 174-179.
30. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, Goedert M,. α-synuclein in Lewy bodies. Nature 1997; 388: 839-840.
31. Feany MB, Bender WW,. A Drosophila model of Parkinson's disease. Nature 2000; 404: 394-398.
32. Masliah E, Rockenstein E, Veinbergs I, et al. Dopaminergic loss and inclusion body formation in α-synuclein mice implications for neurodegenerative disorders. Science 2000; 287: 1265-1269.
33. Braak H, Del Tredici K,. Nervous system pathology in sporadic Parkinson disease. Neurology 2008; 70: 1916-1925.
34. Wakabayashi K, Takahashi H, Takeda S, Ohama E, Ikuta F,. Parkinson's disease: The presence of Lewy bodies in Auerbach's and Meissner's plexuses. Acta Neuropathol. 1988; 76: 217-221.
35. Sengoku R, Saito Y, Ikemura M, et al. Incidence and extent of Lewy body-related alpha-synuclein in aging human olfactory bulb. J. Neuropathol. Exp. Neurol. 2008; 67: 1072-1083.
36. Visanji NP, Brooks PL, Hazrati LN, Lang AE,. The prion hypothesis in Parkinson's disease: Braak to the future. Acta Neuropathol. Commun. 2013; 1: 2.
37. McKeith I, Del Ser T, Spano P, et al. Efficacy of rivastigmine in dementia with Lewy bodies: A randomized, double-blind, placebo-controlled international study. Lancet 2000; 356: 2031-2036.
38. Mori E, Ikeda K, Kosaka K,. Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial. Ann. Neurol. 2012; 72: 41-52.
39. Ikeda M, Mori E, Kosaka K, et al. Long-term safety and efficacy of donepezil in patients with dementia with Lewy bodies: Results from a 52-week, open-label, multi-center extension study. Dement. Geriatr. Cogn. Disord. 2013; 36: 229-241.
40. Kosaka K,. Diffuse Lewy body disease. Neuropathology 2000; 20 (Suppl.): 73-78.